Pilot study of the effect of ultraviolet light on pain and mood in fibromyalgia syndrome

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 1, 2009, Pages 15-23

  Taylor, Sarah L ^a   Kaur, Mandeep ^a   LoSicco, Kristen ^a   Willard, Joy ^a   Camacho, Fabian ^a   O'Rourke, Kenneth S ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROMYALGIA; FOLLOW UP; HUMAN; LITERATURE; MALE; MCGILL PAIN QUESTIONNAIRE; MOOD; PAIN ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; RADIATION EXPOSURE; RADIATION RESPONSE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RELAXATION TIME; THERAPY EFFECT; ULTRAVIOLET RADIATION; VISUAL ANALOG SCALE; WELLBEING;

ADULT; AFFECT; FEMALE; FIBROMYALGIA; HUMANS; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PILOT PROJECTS; RELAXATION; ULTRAVIOLET THERAPY;

EID: 58849149847     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2008.0167     Document Type: Article

References (44)

1. Wolfe F, Smythe HA, Yunus MB, Bennett RM, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990;33:160-172.
2. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Questions and answers about fibromyalgia. [web document]. Bethesda, MD, Dec 1999 [rev.June 2004; cited 26 Feb 2007]. 〈http://www.niams. nih.gov〉.
3. Wolfe F, Ross K, Anderson J, Russell IJ, et al. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 1995;38:19-28.
4. Mayo Foundation for Medical Education and Research (MFMER). Fibromyalgia. [web document]. Rochester, MN, Jan 2007 [cited 27 Feb 2007]. 〈http://www.mayoclinic.com〉.
5. Fan P, Blanton M. Clinical features and diagnostics of fibromyalgia. J Muscoskel Med 1992;9:24-42.
6. Karimova NK. Concentrated sunlight in the therapy of patients with rheumatoid arthritis. Vopr Kurortol Fizioter Lech Fiz Kult 1988 Sep-Oct:34-37.
7. Nies K. Treatment of the fibromyalgia syndrome. J Musculoskel Med 1992;9:20-26.
8. Feldman SR, Liguori A, Kucenic M, Rapp SR, et al. Ultraviolet exposure is a reinforcing stimulus in frequent indoor tanners. J Am Acad Dermatol 2004;51:45-51.
9. Kaur M, Feldman SR, Liguouri A, Fleischer AB Jr. Indoor tanning relieves pain. Photodermatol Photoimmunol Photomed 2005;21:1.
10. Kucenic, Patel M, Feldman SR, Liguori A, et al. Visual discrimination testing of ultraviolet transmitting and ultraviolet blocking acrylic thermoplastics. Photodermatol Photoimmunol Photomed 2002;18:228-231.
11. Melzack R. The short-form McGill Pain Questionnaire. Pain 1987;30:191-197.
12. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the Visual Analogue Scale: Pain 1983;16:87-101.
13. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia Impact Questionnaire (FIQ): Development and validation. J Rheumatol 1991;18:728-733.
14. Bennett R. The Fibromyalgia Impact Questionnaire (FIQ): A review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005;23(suppl 39):S154-S162.
15. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 1988;54:1063-1070.
16. Likert RA. A technique for the measurement of attitudes. Arch Psychol 1932;140:5.
17. Staud R, Rodriguez ME. Mechanisms of disease: Pain in fibromyalgia syndrome. Nat Clin Pract Rheumatol 2006;2:90-98.
18. Dadabhoy D, Clauw DJ. Therapy insight: fibromyalgia - A different type of pain needing a different type of treatment. Nat Clin Pract Rheumatol 2006;2:364-372.
19. Goldenberg DL, Burckhardt C, Crofford L. Management of fibromyalgia syndrome. JAMA 2004;292:2388-2395.
20. Mannerkorpi K. Exercise in fibromyalgia. Curr Opin Rheumatol 2005;17:190-194.
21. Jones KD, Adams D, Winters-Stone K, Burckhardt CS. A comprehensive review of 46 exercise treatment studies in fibromyalgia (1988-2005). Health Qual Life Outcomes 2006;4:67.
22. Mayhew E, Ernst E. Acupuncture for fibromyalgia - A systematic review of randomized clinical trials. Rheumatology 2007;46:801-804.
23. Pearl SJ, Lue F, MacLean AW, Heslegrave RJ, et al. The effects of bright light treatment on the symptoms of fibromyalgia. J Rheumatol 1996;23:896-902.
24. Glickman G, Byrne B, Pineda C, Hauck WW, et al. Light therapy for seasonal affective disorder with blue narrow-band light-emitting diodes (LEDs). Biol Psychiatry 2006;59:502-507.
25. Zanolli M. The modern paradigm of phototherapy. Dermatol Clin 2003;21:398-406.
26. Zanolli M. Phototherapy arsenal in the treatment of psoriasis. Dermatol Clin 2004;22:397-406, viii.
27. van de Kerkhof PC, Vissers WH. Established treatments of psoriasis. Curr Drug Targets Inflamm Allergy 2004;3:145-156.
28. Chang A, Alkemade JA, van de Kerkhof PC. PUVA and UVB inhibit the intra-epidermal accumulation of polymorphonuclear leukocytes. Br J Dermatol 1988;119:281-287.
29. Morison WL, Parrish JA, Woehler ME, Krugler JI, et al. Influence of PUVA and UVB radiation on delayed hypersensitivity in the guinea pig. J Invest Dermatol 1981;76:484-488.
30. Morison WL, Parrish JA, Woehler ME, Bloch KJ. The influence of ultraviolet radiation on allergic contact dermatitis in the guinea-pig. I. UVB radiation. Br J Dermatol 1981;104:161-164.
31. Kripke ML, Morison WL. Studies on the mechanism of systemic suppression of contact hypersensitivity by UVB radiation. II. Differences in the suppression of delayed and contact hypersensitivity in mice. J Invest Dermatol 1986;86:543-549.
32. Cooper KD. Cell-mediated immunosuppressive mechanisms induced by UV radiation. Photochem Photobiol 1996;63:400-406.
33. Schwarz T. Regulatory T cells induced by ultraviolet radiation. Int Arch Allergy Immunol 2005;137:187-193.
34. Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur J Dermatol 2003;13:515-523.
35. Roberts LK, Smith DR, Seilstad KH, Jun BD. Photoimmunology: The mechanisms involved in immune modulation by UV radiation. J Photochem Photobiol B 1988;2:149-177.
36. Woolf CJ. Pain: Moving from symptom control toward mechanism-specific pharmacologic management. Ann Intern Med 2004;140:441-451.
37. Roosterman D, Goerge T, Schneider SW, Bunnett NW, et al. Neuronal control of skin function: The skin as a neuroimmunoendocrine organ. Physiol Rev 2006;86:1309-1379.
38. Seiffert K, Granstein RD. Neuropeptides and neuroendocrine hormones in ultraviolet radiation-induced immunosuppression. Methods 2002;28:97-103.
39. Yosipovitch G, Fleischer A. Itch associated with skin disease: Advances in pathophysiology and emerging therapies. Am J Clin Dermatol 2003;4:617-622.
40. Holick M. Optimal vitamin D status for the prevention and treatment of osteoporosis. Drugs Aging 2007;24:1017-1029.
41. Faiz S, Panunti B, Andrews S. The epidemic of vitamin D deficiency. J La State Med Soc 2007;159:17-20; quiz 20, 55; review.
42. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, et al. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2007;26:551-554.
43. Huisman AM, White KP, Algra A, Harth M, et al. Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol 2001;28:2535-2539.
44. Holick MF, Chen TC, Lu Z, Sauter E. Vitamin D and skin physiology: A D-lightful story. J Bone Miner Res 2007;22 (suppl2):V28-33.